Hillsdale Investment Management Inc. Ironwood Pharmaceuticals Inc Transaction History

Hillsdale Investment Management Inc.

  • $1.21 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$5.58 - $8.61 $35,712 - $55,104
-6,400 Reduced 3.74%
164,800 $1.07 Million
Q1 2024

May 10, 2024
BUY
$8.32 - $15.45 $114,816 - $213,210
13,800 Added 8.77%
171,200 $1.49 Million
Q4 2023

Feb 09, 2024
BUY
$8.79 - $11.51 $1.38 Million - $1.81 Million
157,400 New
157,400 $1.8 Million
Q2 2023

Aug 11, 2023
BUY
$10.1 - $11.6 $34,340 - $39,440
3,400 Added 0.81%
424,017 $4.51 Million
Q4 2022

Feb 13, 2023
BUY
$9.9 - $12.43 $16,830 - $21,131
1,700 Added 0.41%
420,617 $5.21 Million
Q3 2022

Nov 10, 2022
BUY
$10.14 - $12.38 $855,816 - $1.04 Million
84,400 Added 25.23%
418,917 $4.34 Million
Q2 2022

Aug 12, 2022
SELL
$11.05 - $12.72 $22,100 - $25,440
-2,000 Reduced 0.59%
334,517 $3.86 Million
Q1 2022

Apr 28, 2022
SELL
$10.61 - $12.88 $32,891 - $39,928
-3,100 Reduced 0.91%
336,517 $4.23 Million
Q4 2021

Feb 07, 2022
SELL
$10.86 - $13.95 $10,860 - $13,950
-1,000 Reduced 0.29%
339,617 $3.96 Million
Q3 2021

Oct 21, 2021
BUY
$11.92 - $13.92 $452,960 - $528,960
38,000 Added 12.56%
340,617 $4.45 Million
Q1 2021

Apr 22, 2021
BUY
$9.04 - $11.86 $2.74 Million - $3.59 Million
302,617 New
302,617 $3.38 Million

Others Institutions Holding IRWD

# of Institutions
238
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $541M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Hillsdale Investment Management Inc. Portfolio

Follow Hillsdale Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email